Engineered Cyclotides with Potent Broad in Vitro and in Vivo Antimicrobial Activity-Reference-Cited by-同舟云学术

Engineered Cyclotides with Potent Broad in Vitro and in Vivo Antimicrobial Activity

Published:2021-08-06 Issue:49 Volume:27 Page:12702-12708
ISSN:0947-6539
Container-title:Chemistry – A European Journal
language:en
Short-container-title:Chem. Eur. J.

Author:

Ganesan Rajasekaran¹,Dughbaj Mansour A.¹²,Ramirez Lisa³,Beringer Steven²,Aboye Teshome L.¹,Shekhtman Alexander³,Beringer Paul M.²,Camarero Julio A.¹²⁴^ORCID

Affiliation:

1. Department of Pharmacology and Pharmaceutical Sciences School of Pharmacy University of Southern California Los Angeles CA 90033 USA

2. Department of Clinical Pharmacy, School of Pharmacy University of Southern California Los Angeles CA 90033 USA

3. Department of Chemistry State University of New York Albany NY 12222 USA

4. Norris Comprehensive Cancer Center Keck School of Medicine University of Southern California Los Angeles CA 90033 USA

Funder

National Institute of General Medical Sciences

National Human Genome Research Institute

National Institute of Dental and Craniofacial Research

American Foundation for Pharmaceutical Education

Publisher

Wiley

Subject

General Chemistry,Catalysis,Organic Chemistry

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/chem.202101438

Reference83 articles.

1. Appropriate antimicrobial therapy in the era of multidrug-resistant human pathogens

3. Mechanisms of Antimicrobial Resistance in ESKAPE Pathogens

4. ESKAPEing the labyrinth of antibacterial discovery

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Display Technologies for Expanding the Pharmaceutical Applications of Cyclotides;Israel Journal of Chemistry;2024-05-06

2. On the Cyclization of Non‐cyclic Peptides for Biological Applications: Inspiration from Naturally Cyclic Peptides;ChemistrySelect;2023-10-02

3. Synergistic efficacy of tigecycline combined with apramycin againsttet(X)-harboringAcinetobacter spp.;2023-07-23

4. A Synthetic Cyclized Antimicrobial Peptide with Potent Effects against Drug-Resistant Skin Pathogens;ACS Infectious Diseases;2023-05-03

5. Resistance is futile: targeting multidrug-resistant bacteria with de novo Cys-rich cyclic polypeptides;RSC Chemical Biology;2023